Whole grain guidance
This article was originally published in The Tan Sheet
Claims on whole grain products should not imply a "particular level of the ingredient" such as "high" or "excellent source," FDA says in whole grain label statements draft guidance published in the Feb. 17 1Federal Register. Manufacturers may make factual statements such as "100% whole grain" or "10 grams of whole grains" and may use heart disease/certain cancer risk reduction health claims for qualifying foods, according to the draft. The agency defines which grains and forms qualify as whole grains in the document. Comments on the draft are due April 18...
You may also be interested in...
Inovio Pharmaceuticals has reported promising initial data from its first Phase III study of its electrical current-driven DNA plasmid-based immunotherapy, VGX-3100, in virus-associated cervical dysplasia; it is heading a small group of companies evaluating novel therapies in the condition, which often advances to cancer.
In the month ahead, a key ANDA approval could come for Viatris, while additional competition to Gilead Sciences’ Truvada for PrEP is on the way in the US following Teva and Amneal’s launches.
Sensyne obtained UK regulatory approval for its SYNE-COV machine learning algorithm to assess the long-term risks of COVID-19.